ENTITY
Kelun Biotech

Kelun Biotech (1885133D CH)

26
Analysis
Health CareChina
Kelun Biotech operates biotechnology businesses. The Company develops and provides biological drugs, chemical raw materials, chemical preparations, and other products. Kelun Biotech also operates import and export businesses.
more
Refresh
17 Jun 2024 12:18

How to Stimulate China's Consumption, Part III

China's healthcare system is supply efficient, which leads to underpaying the healthcare professionals' service but overmedicates. To change,...

bearishWuXi XDC Cayman
08 May 2024 07:00

Wuxi XDC Lock-Up - US$300m Lockup Expiry Could See Some Selling Owing to the Regulatory Overhang

WuXi XDC Cayman (2268 HK) was listed in Hong Kong on 17th Nov 2023 after raising US$470m. Its six-month lockup will expire on 16th May 2024.

Logo
378 Views
Share
bullishWuXi XDC Cayman
16 Nov 2023 08:09

WuXi XDC Cayman IPO Trading - Strong Subscription Rates Heading into Listing

WuXi XDC Cayman (1877628D HK) raised US$470m in its Hong Kong IPO. In our previous notes, we looked at the company’s past performance and...

Logo
443 Views
Share
bullishWuXi XDC Cayman
07 Nov 2023 11:39

WuXi XDC Cayman IPO - Decent Upside from IPO Range, Bulk of the Deal Taken up by Marquee Investors

WuXi XDC Cayman (1877628D HK) is looking to raise US$470m in its Hong Kong IPO. In this note, we will look at the deal dynamics and share our final...

Logo
639 Views
Share
bullishWuXi XDC Cayman
06 Nov 2023 14:19

WuXi XDC Cayman Pre-IPO - BULL/BEAR Scenario Considerations for Valuations

WuXi XDC Cayman (1877628D HK) is looking to raise around US$500m in its upcoming Hong Kong IPO. In this note, we share our updated thoughts on...

Logo
403 Views
Share
x